DNA repair mutations act as a switch for bowel cancer

FHS
July 5, 2024
2:40 pm

Bowel cancer cells have the ability to regulate their growth using a genetic on-off switch to maximize their chances of survival, a phenomenon that’s been observed for the first time by researchers at UCL and University Medical Center Utrecht.

Kronos stops work on leukemia drug; Aldeyra shares rally on eczema data; Atavistik Bio’s $40M

Kronos Bio stops blood cancer program: The biotech on Monday said Phase Ib data of lanraplenib in a mutated subset of acute myeloid leukemia patients

December 20, 2023

Eiger files for bankruptcy and will wind down operations after years of setbacks

Eiger BioPharmaceuticals said Monday morning that it filed for Chapter 11 protection in the United States Bankruptcy Court for the Northern District of Texas. The

April 2, 2024

Microgravity: the future of R&D? – Pharmaceutical Technology

Space: the final frontier…for manufacturing under microgravity conditions. Products made in space could become crucial for R&D in a wide range of industries, especially healthcare.

July 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.